Binding of Sp 1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC 3 cells

http://bloodjournal.hematologylibrary.org/content/100/9/3325.full.html Updated information and services can be found at: (4217 articles) Neoplasia • Articles on similar topics can be found in the following Blood collections http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml Information about subscriptions and ASH membership may be found online at:

[1]  M. Bustin.  Revised nomenclature for high mobility group (HMG) chromosomal proteins. , 2001, Trends in biochemical sciences.

[2]  J. Berthelsen,et al.  Oct-1 specifically binds the UEF4 site of the human AP1-regulated urokinase enhancer. , 2000, European journal of biochemistry.

[3]  R. Wisdom,et al.  AP-1: one switch for many signals. , 1999, Experimental cell research.

[4]  Y. Nagamine,et al.  Regulation by p38 mitogen-activated protein kinase of adenylate- and uridylate-rich element-mediated urokinase-type plasminogen activator (uPA) messenger RNA stability and uPA-dependent in vitro cell invasion. , 1999, Cancer research.

[5]  G. Suske.  The Sp-family of transcription factors. , 1999, Gene.

[6]  P. Verde,et al.  Role of Distinct Mitogen-Activated Protein Kinase Pathways and Cooperation between Ets-2, ATF-2, and Jun Family Members in Human Urokinase-Type Plasminogen Activator Gene Induction by Interleukin-1 and Tetradecanoyl Phorbol Acetate , 1999, Molecular and Cellular Biology.

[7]  D. Gomez,et al.  Deregulation of the signaling pathways controlling urokinase production. Its relationship with the invasive phenotype. , 1999, European journal of biochemistry.

[8]  Y. Nagamine,et al.  Transcriptional Regulation of the Murine Urokinase-type Plasminogen Activator Gene in Skeletal Myoblasts , 1999, Thrombosis and Haemostasis.

[9]  N. Hernandez,et al.  The Oct-1 POU domain activates snRNA gene transcription by contacting a region in the SNAPc largest subunit that bears sequence similarities to the Oct-1 coactivator OBF-1. , 1998, Genes & development.

[10]  J. Berthelsen,et al.  The novel homeoprotein Prep1 modulates Pbx–Hox protein cooperativity , 1998, The EMBO journal.

[11]  J. Berthelsen,et al.  Prep1, a novel functional partner of Pbx proteins , 1998, The EMBO journal.

[12]  D. Hume,et al.  Cooperation of two PEA3/AP1 sites in uPA gene induction by TPA and FGF-2. , 1997, Gene.

[13]  J. Berthelsen,et al.  Characterization of UEF-4, a DNA-binding Protein Required for Transcriptional Synergism between Two AP-1 Sites in the Human Urokinase Enhancer* , 1997, The Journal of Biological Chemistry.

[14]  J. Horowitz,et al.  Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. , 1997, Nucleic acids research.

[15]  Barbara Majello,et al.  Sp3 Is a Bifunctional Transcription Regulator with Modular Independent Activation and Repression Domains* , 1997, The Journal of Biological Chemistry.

[16]  R. Paro,et al.  Analysis of chromatin structure by in vivo formaldehyde cross-linking. , 1997, Methods.

[17]  F. Blasi,et al.  Functional characterization of COM, a DNA region required for cooperation between AP-1 sites in urokinase gene transcription. , 1996, Oncogene.

[18]  M. Beato,et al.  An inhibitor domain in Sp3 regulates its glutamine‐rich activation domains. , 1996, The EMBO journal.

[19]  P. Verde,et al.  Signal transduction and the u-PA/u-PAR system , 1996 .

[20]  L. Lania,et al.  Sp3 Represses Transcription When Tethered to Promoter DNA or Targeted to Promoter Proximal RNA (*) , 1996, The Journal of Biological Chemistry.

[21]  J. Berthelsen,et al.  Purification and Characterization of UEF3, A Novel Factor Involved in the Regulation of the Urokinase and Other AP-1 Controlled Promoters (*) , 1996, The Journal of Biological Chemistry.

[22]  M. Beato,et al.  Functional Analyses of the Transcription Factor Sp4 Reveal Properties Distinct from Sp1 and Sp3 (*) , 1995, The Journal of Biological Chemistry.

[23]  L. Lania,et al.  Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins. , 1995, Oncogene.

[24]  L. Lania,et al.  Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. , 1994, Nucleic acids research.

[25]  M. Beato,et al.  Sp1‐mediated transcriptional activation is repressed by Sp3. , 1994, The EMBO journal.

[26]  Y. Nagamine,et al.  Activation of cAMP-dependent protein kinase alters the chromatin structure of the urokinase-type plasminogen activator gene promoter. , 1994, Nucleic acids research.

[27]  T. Curran,et al.  Selective DNA bending by a variety of bZIP proteins , 1993, Molecular and cellular biology.

[28]  P. Verde,et al.  A regulatory element that mediates co‐operation between a PEA3‐AP‐1 element and an AP‐1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. , 1992, The EMBO journal.

[29]  M. Beato,et al.  Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. , 1992, Nucleic acids research.

[30]  A. Winoto,et al.  Cloning of GT box-binding proteins: a novel Sp1 multigene family regulating T-cell receptor gene expression , 1992, Molecular and cellular biology.

[31]  L. Lund,et al.  Differential expression of urokinase-type plasminogen activator and its type-1 inhibitor during healing of mouse skin wounds. , 1991, The Journal of investigative dermatology.

[32]  P. Rørth,et al.  Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type-specific activity. , 1991, Oncogene.

[33]  P. Rennie,et al.  A cell-type specific and enhancer-dependent silencer in the regulation of the expression of the human urokinase plasminogen activator gene. , 1991, Nucleic acids research.

[34]  R. Tjian,et al.  DNA looping between sites for transcriptional activation: self-association of DNA-bound Sp1. , 1991, Genes & development.

[35]  R. Tjian,et al.  GC box binding induces phosphorylation of Sp1 by a DNA-dependent protein kinase , 1990, Cell.

[36]  P. Verde,et al.  An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene. , 1988, Nucleic acids research.

[37]  L. Orci,et al.  Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells , 1987, The Journal of cell biology.

[38]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[39]  J. Lechner,et al.  Establishment and characterization of a human prostatic carcinoma cell line (PC-3). , 1979, Investigative urology.

[40]  A. Angelucci,et al.  Vesicle-associated urokinase plasminogen activator promotes invasion in prostate cancer cell lines , 2004, Clinical & Experimental Metastasis.

[41]  J. Nip,et al.  Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3. , 2001, International journal of cancer.

[42]  R. Krumlauf,et al.  Segmental expression of Hoxb2 in r4 requires two separate sites that integrate cooperative interactions between Prep1, Pbx and Hox proteins. , 2000, Development.

[43]  K. Struhl,et al.  Current Protocols in Molecular Biology (New York: Greene Publishing Associates and Wiley-Interscience). Host-Range Shuttle System for Gene Insertion into the Chromosomes of Gram-negative Bacteria. , 1988 .

[44]  G. Contreras,et al.  Heterotransplantation studies with tissue culture cell lines in various animal and in vitro host systems. , 1985, Journal of biological standardization.

[45]  S. T. Rohrlich,et al.  The role of proteinases in cellular invasiveness. , 1983, Biochimica et biophysica acta.